BREAKING NEWS
Cloud Server Hosting For Online Businesses
Inexpensive SEO Services
Benefits of Wanting to play Free Online Slot machines
Somatrem

Summary

Somatrem, sold under the brand name Protropin, is an analogue of growth hormone (GH).[1]

Somatrem
Clinical data
Trade namesProtropin
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC code
Identifiers
CAS Number
  • 82030-87-3 ☒N
DrugBank
  • DB09098 checkY
ChemSpider
  • none
UNII
  • CU8D464EDW
KEGG
  • D05884 checkY
ChEMBL
  • ChEMBL1201620 ☒N
Chemical and physical data
FormulaC995H1537N263O301S8
Molar mass22256.26 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Overview edit

Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone.

Somatrem was first marketed under the brand name Protropin by Genentech in 1985.[2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[3][circular reference].

Somatrem has largely been replaced by somatropin, marketed by several companies including by Genentech as the brand Nutropin.

References edit

  1. ^ Flodh H (1987). "Present situation worldwide regarding the use and clinical experience of Somatonorm (somatrem)". Acta Paediatrica Scandinavica. Supplement. 331: 1–4. doi:10.1111/j.1651-2227.1987.tb17089.x. PMID 3300150. S2CID 20410776.
  2. ^ "Genentech: Press Releases - Friday, Oct 18, 1985". www.gene.com.
  3. ^ Growth hormone therapy#cite note-32

External links edit

  • "Somatrem". Drug Information Portal.
  • HyperGH 14x Growth Hormone Info.